Ultragenyx Pharmaceutical Inc (STU:UP0) Stock News, Headlines & Updates
Ultragenyx Pharmaceutical Inc Stock News from GuruFocus
- 1
Oct 18, 2024
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Marketwired • 4:00pm
Oct 07, 2024
Ultragenyx Receives Breakthrough Therapy Designation for Setrusumab (UX143) in Osteogenesis Imperfecta
Marketwired • 7:00am
Oct 03, 2024
Ultragenyx Provides Update on Stage 1 Cohorts in Pivotal Phase 1/2/3 Cyprus2+ Study Evaluating UX701 Gene Therapy for the Treatment of Wilson Disease
Marketwired • 4:00pm
Sep 26, 2024
Ultragenyx Announces Upcoming Setrusumab (UX143) Presentations at the ASBMR 2024 Annual Meeting
Marketwired • 7:00am
Sep 18, 2024
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Marketwired • 4:00pm
Aug 29, 2024
Ultragenyx to Participate in Investor Conferences in September
Marketwired • 4:00pm
Aug 21, 2024
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Marketwired • 4:00pm
Aug 02, 2024
Ultragenyx Pharmaceutical Inc (RARE) Q2 2024 Earnings Call Transcript Highlights: Strong Revenue Performance and Increased Guidance
GuruFocus Research • 1:16am
Q2 2024 Ultragenyx Pharmaceutical Inc Earnings Call Transcript
GuruFocus Research • 11:18pm
Aug 01, 2024
Ultragenyx Reports Second Quarter 2024 Financial Results and Corporate Update
Marketwired • 4:00pm
Ultragenyx Pharmaceutical Inc (RARE) Q2 2024 Earnings: Revenue Surges to $147 Million, GAAP EPS at -$1.52
GuruFocus Research • 3:58pm
- 1
Show
Entries
Headlines
Total 0- 1
No recent news